CORC

在结果中检索

CORC

浏览/检索结果: 共30条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors 期刊论文
2019, 卷号: 11, 期号: 7
作者:  Geng, Xiuzhu;  Liu, Zixuan;  Yu, Danwei;  Qin, Bo;  Zhu, Yuanmei
收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial 期刊论文
2019, 卷号: 24, 期号: 8, 页码: E702-E708
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Yan;  Luo, Hong;  Ren, Xiu-Bao
收藏  |  浏览/下载：18/0  |  提交时间：2020/01/03
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 16
作者:  Huang, Jing;  Xu, Binghe;  Liu, Ying;  Huang, Junxing;  Lu, Ping
收藏  |  浏览/下载：31/0  |  提交时间：2020/01/03
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial 期刊论文
2018, 卷号: 319, 期号: 24, 页码: 2486-2496
作者:  Li Jin;  Qin Shukui;  Xu Rui-Hua;  Shen Lin;  Xu Jianming
收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03
Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor 期刊论文
2018, 卷号: 293, 期号: 33, 页码: 12703-12718
作者:  Yu, Danwei;  Ding, Xiaohui;  Liu, Zixuan;  Wu, Xiyuan;  Zhu, Yuanmei
收藏  |  浏览/下载：12/0  |  提交时间：2020/01/03
Mechanism of HIV-1 Resistance to an Electronically Constrained alpha-Helical Peptide Membrane Fusion Inhibitor 期刊论文
2018, 卷号: 92, 期号: 7
作者:  Wu, Xiyuan;  Liu, Zixuan;  Ding, Xiaohui;  Yu, Danwei
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity 期刊论文
2017, 卷号: 91, 期号: 11
作者:  Chong Huihui;  Xue Jing;  Xiong Shengwen;  Cong Zhe;  Ding Xiaohui
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
A randomized, double-blind, placebo-controlled, multi-centered phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (FRESCO). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Li, Jin;  Qin, Shukui;  Bai, Yuxian;  Deng, Yanhong;  Yang, Lei
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04
A randomized, double-blind, placebo-controlled, multi-centered phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (FRESCO). 期刊论文
2017, 卷号: 35
作者:  Li, Jin;  Qin, Shukui;  Bai, Yuxian;  Deng, Yanhong;  Yang, Lei
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double‑blinded, placebo‑controlled, phase II clinical trial 期刊论文
2017, 卷号: 36, 期号: 12, 页码: 677-685
作者:  Xu Ruihua;  Shen Lin;  Wang Keming;  Wu Gang;  Shi Chunmei
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace